Is Vertex Pharmaceuticals Stock a Buy Now?
As one of the hottest and most-watched companies in the biopharmaceutical sector, Vertex Pharmaceuticals (NASDAQ: VRTX) has a unique mix of stability and growth potential that's attractive to a broad crowd of investors. Given its collection of medicines on the market and a highly promising pipeline that's packed with some very sophisticated candidates, buying its shares today could be a great decision in five years.
But drug developers tend to be risky bets, even once they're established. So is Vertex a smart purchase this summer, or would it be better to invest in something else?
In short, Vertex is exposed to an abundance of growth opportunities in the near term.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
€461.30
1.100%
The stock is one of the favorites of our community with 55 Buy predictions and 2 Sell predictions.
On the other hand, the target price of 450 € is below the current price of 461.3 € for Vertex Pharmaceuticals Inc., so the potential is actually -2.45%.
